| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $118.6M | +15.2% | +82.1% |
| Cost of Revenue | $85.4M | +18.9% | +73.4% |
| Gross Profit | $33.3M | +6.7% | +109.0% |
| R&D Expense | $21.3M | +3.2% | +58.4% |
| SG&A Expense | $20.3M | +10.5% | +42.7% |
| Operating Income | -$18.2M | -13.8% | -9.9% |
| Pre-tax Income | -$17.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $137.0M | +111.7% | +301.4% |
| Accounts Receivable | $224.0M | +5.9% | +198.1% |
| Inventory | $170.2M | +22.6% | +164.4% |
| Current Assets | $575.3M | +25.5% | +205.4% |
| Total Assets | $978.5M | +22.8% | +138.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$144.9M | — | — |
| Capital Expenditures | $104.1M | — | — |
| Investing Cash Flow | -$125.7M | — | — |
| Financing Cash Flow | $348.2M | — | — |
| Free Cash Flow | -$249.0M | — | — |
| -97.1% |
| -1.0% |
| Income Tax | $0 | — | — |
| Net Income | -$17.9M | -97.1% | -1.0% |
| EPS (Basic) | -$0.28 | -75.0% | +33.3% |
| EPS (Diluted) | -$0.28 | -75.0% | +33.3% |
| $249.1M |
| +14.9% |
| +112.8% |
| Long-term Debt | $0 | — | -100.0% |
| Total Liabilities | $419.4M | +12.8% | +112.0% |
| Stockholders' Equity | $559.1M | +31.6% | +163.6% |